Immunomedics, VenBio Settle Del. Proxy Fight Claims

Law360, Wilmington (February 9, 2018, 9:59 PM EST) -- A far-ranging battle over the leadership of biotechnology firm Immunomedics Inc. largely ended Friday with a Delaware state court judge's approval of a deal to settle most claims lodged by investor venBio Select Advisor LLC.

The settlement resolves direct and derivative claims brought by venBio against most of the Immunomedics directors and its financial advisers in light of a vast improvement in the governance of the company following changes to the board and the unwinding of an asset sale that took place in early 2017.

VenBio attorney...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.